loading

Corbus Pharmaceuticals Holdings Inc Azioni (CRBP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
21.83%
1.314
1.681 3.554 1.189 0.906
Operating Expenses
3.15%
19.15
19.77 12.61 15.51 10.99
Benefits Costs and Expenses
1.70%
18.98
18.66 13.08 14.97 10.90
Costs And Expenses
1.70%
18.98
18.66 13.08 14.97 10.90
Depreciation and Amortization
34.57%
0.053
0.081 0.134 0.152 0.1503
Operating Income/Loss
3.15%
-19.15
-19.77 -12.61 -15.51 -10.99
Nonoperating Income/Loss
46.73%
1.49
2.797 3.075 1.722 0.991
Income/Loss From Continuing Operations Before Tax
4.03%
-17.66
-16.98 -9.53 -13.78 -9.997
Income/Loss From Continuing Operations After Tax
4.03%
-17.66
-16.98 -9.53 -13.78 -9.997
Net Income/Loss
4.03%
-17.66
-16.98 -9.53 -13.78 -9.997
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.31%
12.24
12.20 0.4244 12.01 11.05
Diluted Average Shares
0.31%
12.24
12.20 0.4244 12.01 11.05
Basic Earnings Per Share
3.60%
-1.44
-1.39 -0.76 -1.15 -0.90
Diluted Earnings Per Share
3.60%
-1.44
-1.39 -0.76 -1.15 -0.90
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):